Adam Pass, M.D.
NPI 1184623803 · Ophthalmology Physician · Brooklyn, NY
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Adam Pass, M.D. is a Ophthalmology Physician provider in Brooklyn, NY (NPI 1184623803).
Provider details
- NPI number
- 1184623803
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 182927 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,006 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 485 | $147 |
| Photography of the Retina92250 | 218 | $43 |
| Established Patient Problem Focused Exam of Visual System92012 | 112 | $104 |
| Exam of Visual Field With Extended Testing92083 | 60 | $75 |
| New Patient Complete Exam of Visual System92004 | 42 | $174 |
| Imaging of Retina92134 | 41 | $47 |
| Imaging of Optic Nerve92133 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 172 | 36 |
| Timolol Maleate | 56 | 17 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 54 | 31 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 38 | 12 |
| Bimatoprostbrand: Lumigan | 24 | — |
| Brimonidine Tartrate | 21 | — |
| Travoprost | 17 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$422 across 19 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-14
- Last updated
- 2011-01-24
Frequently asked questions
- What is Adam Pass's NPI number?
- Adam Pass's National Provider Identifier (NPI) is 1184623803, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Adam Pass's specialty?
- Adam Pass is listed in the NPPES registry with a primary specialty of Ophthalmology Physician (Allopathic & Osteopathic Physicians).
- Where is Adam Pass located?
- Adam Pass's practice location on file with NPPES is 522 Bay Ridge Pkwy, Brooklyn, NY 11209-3310.
- What is Adam Pass's phone number?
- The practice phone number listed in the NPPES registry for Adam Pass is (718) 836-1779.
- Does Adam Pass accept Medicare?
- Adam Pass is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Adam Pass's NPI active?
- Yes — Adam Pass's NPI (1184623803) is active in the NPPES registry as of the last update on 2011-01-24.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.